The natural history of gastro-esophageal reflux disease: a comprehensive review

被引:83
|
作者
Savarino, E. [1 ]
de Bortoli, N. [2 ]
de Cassan, C. [1 ]
Della Coletta, M. [1 ]
Bartolo, O. [1 ]
Furnari, M. [3 ]
Ottonello, A. [4 ]
Marabotto, E. [3 ]
Bodini, G. [3 ]
Savarino, V. [3 ]
机构
[1] Univ Padua, Dept Surg Oncol & Gastroenterol, Div Gastroenterol, Via Giustiniani 2, I-35128 Padua, Italy
[2] Univ Pisa, Div Gastroenterol, Dept Translat Res & New Technol Med & Surg, Pisa, Italy
[3] Univ Genoa, Div Gastroenterol, Dept Internal Med, Genoa, Italy
[4] Univ Genoa, Dept Surg Med Sci & Integrated Diagnost, Genoa, Italy
关键词
GERD; NERD; erosive esophagitis; endoscopy; natural history; PUMP INHIBITOR USE; BARRETTS-ESOPHAGUS; FUNCTIONAL HEARTBURN; CLINICAL SPECTRUM; RISK-FACTOR; PERSISTENT SYMPTOMS; EROSIVE ESOPHAGITIS; PULMONARY-FIBROSIS; GASTRIC CARDIA; UNITED-STATES;
D O I
10.1111/dote.12511
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gastroesophageal reflux disease (GERD) is a common disorder of the upper gastrointestinal tract which is typically characterized by heartburn and acid regurgitation. These symptoms are widespread in the community and range from 2.5% to more than 25%. Economic analyses showed an increase in direct and indirect costs related to the diagnosis, treatment and surveillance of GERD and its complications. The aim of this review is to provide current information regarding the natural history of GERD, taking into account the evolution of its definition and the worldwide gradual change of its epidemiology. Present knowledge shows that there are two main forms of GERD, that is erosive reflux disease (ERD) and non-erosive reflux disease (NERD) and the latter comprises the majority of patients (up to 70%). The major complication of GERD is the development of Barrett esophagus, which is considered as a pre-cancerous lesion. Although data from medical literature on the natural history of this disease are limited and mainly retrospective, they seem to indicate that both NERD and mild esophagitis tend to remain as such with time and the progression from NERD to ERD, from mild to severe ERD and from ERD to Barrett's esophagus may occur in a small proportion of patients, ranging from 0 to 30%, 10 to 22% and 1 to 13% of cases, respectively. It is necessary to stress that these data are strongly influenced by the use of powerful antisecretory drugs (PPIs). Further studies are needed to better elucidate this matter and overcome the present limitations represented by the lack of large prospective longitudinal investigations, absence of homogeneous definitions of the various forms of GERD, influence of different treatments, clear exclusion of patients with functional disorders of the esophagus.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Gastro-esophageal reflux in adults: definition, epidemiology and natural history
    Bommelaer, G
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1999, 23 (1BIS): : S3 - S9
  • [2] Histologic definition of gastro-esophageal reflux disease
    Chandrasoma, Parakrama T.
    CURRENT OPINION IN GASTROENTEROLOGY, 2013, 29 (04) : 460 - 467
  • [3] Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024
    Visaggi, Pierfrancesco
    Bertin, Luisa
    Pasta, Andrea
    Calabrese, Francesco
    Ghisa, Matteo
    Marabotto, Elisa
    Ribolsi, Mentore
    Savarino, Vincenzo
    de Bortoli, Nicola
    Savarino, Edoardo Vincenzo
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (15) : 2077 - 2088
  • [4] Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease
    Gold, Benjamin D.
    Pilmer, Betsy
    Kierkus, Jaroslaw
    Hunt, Barbara
    Perez, Maria Claudia
    Gremse, David
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (11) : 3059 - 3068
  • [5] Obesity and gastro-esophageal reflux disease: a 2009 update
    Garita, F. Senapeschi
    Pellicano, R.
    Fagoonee, S.
    Strona, S.
    Cukier, C.
    Magnoni, C. D.
    MINERVA MEDICA, 2009, 100 (03) : 213 - 219
  • [6] Therapeutic strategies for gastro-esophageal reflux disease
    Labenz, J.
    Leodolter, A.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2007, 45 (11): : 1169 - 1179
  • [7] Complications of gastro-esophageal reflux disease.
    Evrard, S
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1999, 23 (1BIS): : S221 - S228
  • [8] Gastro-esophageal reflux disease in primary care practice: a narrative review
    Kazakova, Tatiana
    Danoff, Robert
    Esteva, Irina
    Shchurin, Aleksey
    ANNALS OF ESOPHAGUS, 2023, 6
  • [9] Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease
    Savarino, Vincenzo
    Marabotto, Elisa
    Zentilin, Patrizia
    Furnari, Manuele
    Bodini, Giorgia
    De Maria, Costanza
    Tolone, Salvatore
    De Bortoli, Nicola
    Frazzoni, Marzio
    Savarino, Edoardo
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (04) : 437 - 449
  • [10] Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art
    Savarino, Vincenzo
    Marabotto, Elisa
    Zentilin, Patrizia
    Demarzo, Maria Giulia
    de Bortoli, Nicola
    Savarino, Edoardo
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 1609 - 1621